[1]
Shambhavi, S. et al. 2025. Demographic Variations in Immune Checkpoint Inhibitor Adverse Events: A Real-World Study. World Journal of Oncology. (Aug. 2025). DOI:https://doi.org/10.14740/wjon2612.